Skip to main content

What the FDA labels say about taking them together

Alprazolam and aprepitant

Aprepitant's FDA label of July 5, 2024 names alprazolam in its drug interactions section; the alprazolam labels PlainMeds reads (2) do not name aprepitant. The aprepitant label: “Clinical Impact; Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions.”

Check it at the source: the alprazolam FDA label on DailyMed (effective January 18, 2023, PHARMACIA & UPJOHN COMPANY LLC); the aprepitant FDA label on DailyMed (effective July 5, 2024, Merck Sharp & Dohme LLC).

What does the alprazolam label say about aprepitant?

Alprazolam's label (effective January 18, 2023) and its 1 other brand-application label do not name aprepitant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Xanax), PHARMACIA & UPJOHN COMPANY LLC, effective January 18, 2023 (SPL set 388e249d-b9b6-44c3-9f8f-880eced0239f), via openFDA; the full label on DailyMed

What does the aprepitant label say about alprazolam?

Aprepitant label, drug interactions

Clinical Impact; Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions [see ].

Source: FDA drug label (EMEND), NDA021549 (Msd), as published by Merck Sharp & Dohme LLC, effective July 5, 2024 (SPL set 696f9e80-9cae-403b-de9e-078343ce4713), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

30Alprazolam generic labelers
5Aprepitant generic labelers
AlprazolamAprepitant
Labeled forAnxietyNausea and vomiting
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0236 per tablet 0.25 mg tablet$46.42 per capsule 40 mg capsule
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?